About the role

Aplyr's Quick Take

This role is for an Associate Director in Bioanalytical Sciences, focusing on designing and executing bioanalytical strategies for drug development related to obesity. You'll oversee outsourced bioanalysis, ensure GLP compliance, and work closely with cross-functional teams. It's a senior individual contributor position with leadership responsibilities.

Good fit

Ideal candidates have over 10 years of experience in bioanalytical sciences, particularly in clinical and non-clinical studies. Strong project management skills and a collaborative working style are essential.

Worth noting

The role requires being onsite 3-4 days a week in Waltham, MA, which may not suit those looking for remote flexibility. The position involves significant oversight of CROs, which can be a challenging aspect for some.

At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.

We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.

What You’ll Do:

The Associate Director, Bioanalytical Sciences at Kailera Therapeutics will report to the Director, Bioanalytical Sciences and will be responsible for designing and executing bioanalytical strategies to support development programs for patients with obesity-related diseases. This role will oversee GLP-compliant bioanalytical work for non-clinical and clinical studies. The Associate Director will manage CRO-outsourced bioanalysis to advance drug candidates through various development stages while partnering with cross-functional teams to ensure the seamless integration of data into Kailera’s broader development programs.

Required location: Waltham, MA (hub-based, onsite 3-4 days per week)

Responsibilities:

Lead bioanalytical strategy and execution in clinical and non-clinical studies
Collaborate with cross-functional teams to design and implement bioanalytical aspects of clinical development programs
Identify, select, and oversee CROs, ensuring adherence to timelines, budgets, and regulatory requirements
Manage and oversee outsourced bioanalysis of small molecules, peptides, and biomarkers
Direct the development, validation, and implementation of bioanalytical assays
Review validation protocols, test procedures, raw data, and technical reports to ensure scientific rigor and compliance with regulatory guidelines
Provide leadership in ensuring GLP compliance for bioanalysis in both non-clinical and clinical trials
Author and review bioanalytical sections of regulatory submissions
Represent the bioanalytical function in cross-functional project teams

Required Qualifications:

10+ years of relevant industry experience in bioanalytical sciences with a Bachelor’s degree or 5+ years with an advanced degree
Expertise in regulated bioanalysis and clinical-stage drug development
In-depth knowledge of GLP/GCP requirements and industry best practices in bioanalytical laboratories
Proven experience in the regulatory requirements for method development and validation
Strong track record of managing CRO-outsourced bioanalysis and vendor relationships
Excellent project management skills with the ability to manage multiple priorities effectively
Experience with regulatory interactions is highly desirable
Experience contributing to regulatory filings for biologics and small molecules

Preferred Qualifications:

Experience with GLP-1 receptor agonists or related therapeutic areas
Strong understanding of bioanalytical considerations for incretin-based therapies

Education:

Bachelor's degree in a relevant scientific discipline required (e.g., bioanalytical chemistry, pharmacology, or related field); PhD preferred

Salary Range

$159,000—$195,000 USD

For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.

EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:

Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.

E-Verify:

Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.

#LI-Hybrid

Skills & Tags

go aws gcp ai data product design

Aplyr's read

Kailera Therapeutics pioneers gene editing for rare diseases, attracting talent in quality assurance, clinical development, and scientific communications.
Synthesized from recent postings & public sources

What's promising

•Focus on rare diseases fills a critical healthcare niche.
•Recent hires indicate strong emphasis on quality and regulatory compliance.
•Advanced gene editing technologies position the company at the forefront of biotech innovation.

What to watch

•High reliance on unproven gene editing technologies carries inherent risks.
•Intense competition in biotech may challenge market positioning.
•Limited public information about financial stability and long-term viability.

Why Kailera Therapeutics

•Specializes in rare disease therapies, a less crowded market segment.
•Emphasizes a robust quality assurance framework through strategic hires.
•Integrates cutting-edge gene editing with a focus on clinical development.

Aplyr’s read is generated by AI from public sources. Was it useful?

About Kailera Therapeutics

Kailera Therapeutics

kaileratx.com

View company

Kailera Therapeutics is a biotechnology company focused on developing innovative therapies for rare diseases using advanced gene editing technologies.